APA (7th ed.) Citation

GG, K., KK, B., AL, C., WP, H., SA, C., V, S., . . . EG, C. (2025). Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers. Cancers, 17(11), . https://doi.org/10.3390/cancers17111830

Chicago Style (17th ed.) Citation

GG, King, et al. "Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers." Cancers 17, no. 11 (2025). https://doi.org/10.3390/cancers17111830.

MLA (9th ed.) Citation

GG, King, et al. "Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers." Cancers, vol. 17, no. 11, 2025, https://doi.org/10.3390/cancers17111830.